title: Comment on: Failure of combination therapy with daptomycin and synergistic ceftriaxone for enterococcal endocarditis.
authors.affiliation: Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI, USA.
authors.forename: Ashley
authors.initials: A
authors.lastname: Hall Snyder
authors.affiliation: Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI, USA Department of Pharmacy, University of Washington, Seattle, WA, USA.
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Werth
authors.affiliation: Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI, USA.
authors.forename: Katie E
authors.initials: KE
authors.lastname: Barber
authors.affiliation: Department of Pediatrics, University of San Diego School of Medicine, San Diego, CA, USA Infectious Diseases, Sharp Memorial Hospital, San Diego, CA, USA.
authors.forename: George
authors.initials: G
authors.lastname: Sakoulas
authors.affiliation: Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI, USA School of Medicine, Wayne State University, Detroit, MI, USA m.rybak@wayne.edu.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Rybak
mesh_terms: D002443:Ceftriaxone / Q000494:pharmacology*; D017576:Daptomycin / Q000494:pharmacology*; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D013293:Enterococcus faecalis / Q000187:drug effects*; D065507:Vancomycin-Resistant Enterococci / Q000187:drug effects*
chemical_list: D002443:Ceftriaxone; D017576:Daptomycin
keywords: enterococci; morbidity; mortality; treatment